Summary

Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.

Job description

What You'll Do

Work with department managers to repair/adjust/update software settings for existing automated workflows in a complex, rapidly-evolving clinical laboratory at multiple sites.
Provide technical support for liquid handlers and other lab instrumentation, and coordinate with third-party support engineers as needed.
Collaborate with Clinical Lab, QC and Lab Automation teams to coordinate, schedule and perform non-routine maintenance of instrumentation.
Help create and implement new equipment functionality for use by Tempus R&D and clinical lab staff while maintaining CLIA/CAP/NYS-DOH/ISO compliance.
Complete Performance Qualifications (PQs) for all clinically approved molecular laboratory equipment.
Collect and help analyze equipment metrics.
Investigate equipment related issues and help facilitate and implement corrective and preventative actions.
Interact with lab management and testing personnel to provide equipment training, troubleshoot equipment issues, and prioritize QC tasks.
Report significant equipment findings/deviations and system deficiencies to lab management, as appropriate.
Update SOPs and equipment records within the document control system, including creation/revision/review of internal SOPs and other quality documentation.

Qualifications

B.S. or M.S. in Bioengineering, Biotechnology, or other applicable Life Science, with 2-6 years experience in programming or building automation systems in a pharmaceutical, biotechnology, or clinical laboratory.
Highly organized and systematic, superb attention to detail and ability to complete tasks with a high degree of accuracy.
Proven ability to learn new skills quickly and adapt to new processes smoothly.
Moderate experience with Microsoft Excel and/or Google Sheets.
Previous experience in a clinical lab regulated by CAP/CLIA/NYS, highly desirable.
Good time management skills.
Experience with Tecan Liquid Handlers, highly desirable.

Requirements

B.S. or M.S. in Bioengineering, Biotechnology, or other applicable Life Science
2-6 years experience in programming or building automation systems in a pharmaceutical, biotechnology, or clinical laboratory
Highly organized and systematic with superb attention to detail
Proven ability to learn new skills quickly and adapt to new processes
Moderate experience with Microsoft Excel and/or Google Sheets
Good time management skills
Previous experience in a clinical lab regulated by CAP/CLIA/NYS (desirable)
Experience with Tecan Liquid Handlers (desirable)

Benefits

Incentive Compensation
Restricted Stock Units
Medical Benefits

Company overview

Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.